Skip to main content
ACR Open Rheumatology logoLink to ACR Open Rheumatology
. 2026 Sep 30;8(10):e90161. doi: 10.1002/acr2.90161

Clinical Images: Rapidly progressive granulocyte colony‐stimulating factor–associated arteritis: initial normal imaging as a diagnostic pitfall

Chika Kayabe Kuroda 1, Takashi Nawata 1,✉, Toru Ariyoshi 2, Mayu Nakamoto 2, Noriko Maeda 3, Hidenori Takahashi 3, Hiroshi Nakamura 1, Motoaki Sano 1
PMCID: PMC13626975  PMID: 42816428

graphic file with name ACR2-8-e90161-g001.webp

The patient, a 53‐year‐old Japanese woman, presented to our hospital with fever and right neck pain. She had a history of breast carcinoma and had undergone chemotherapy with sacituzumab govitecan, which required pegfilgrastim. Seven days after the last pegfilgrastim dose, she developed generalized fatigue, fever, and right‐sided neck pain (day 7). Contrast‐enhanced computed tomography (CE‐CT) did not reveal the origin of the fever on day 10 (A). Follow‐up CE‐CT on day 14 showed arterial wall thickening, especially in the right common carotid artery (B). Laboratory examinations revealed elevated serum C‐reactive protein levels (26.68 mg/dL; normal range: below 0.14 mg/dL). Carotid ultrasonography showed thickening of the outer lines around the bifurcation of the right common carotid artery into the external and internal carotid arteries, strongly suggestive of arteritis (C). The patient was diagnosed with granulocyte colony‐stimulating factor (G‐CSF)–associated arteritis. Subsequently, prednisolone (initial dose: 1 mg/kg/day) was administered on day 14, which immediately improved her symptoms. Carotid ultrasonography repeated on day 18 showed an improvement in the wall thickening of the right common carotid artery (D). G‐CSF–associated arteritis improves rapidly upon the discontinuation of G‐CSF formulations or initiation of glucocorticoid therapy. 1 Regarding the onset of arteritis, G‐CSF–associated arteritis tends to present within 10 days of pegfilgrastim administration. 2 , 3 However, the onset pattern of arteritis remains unclear. Our case highlights the importance of frequent follow‐up examinations when G‐CSF–associated arteritis is suspected, even if initial tests show no abnormalities.

Supporting information

Disclosure Statement.

ACR2-8-e90161-s001.docx (34.5KB, docx)

Author disclosures are available at https://onlinelibrary.wiley.com/doi/10.1002/acr2.90161.

References

  • 1. Muzzana M, Pedrazzoli P, Lasagna A. G‐CSF and G‐CSF‐related vasculitis: a systematic review of the literature and intriguing future research perspectives. Future Oncol 2021;17(33):4619–4634. doi: 10.2217/fon-2021-0701 [DOI] [PubMed] [Google Scholar]
  • 2. Hoshina H, Takei H. Granulocyte‐colony stimulating factor‐associated aortitis in cancer: a systematic literature review. Cancer Treat Res Commun 2021;29:100454. doi: 10.1016/j.ctarc.2021.100454 [DOI] [PubMed] [Google Scholar]
  • 3. Taimen K, Heino S, Kohonen I, et al. Granulocyte colony‐stimulating factor‐ and chemotherapy‐induced large‐vessel vasculitis: six patient cases and a systematic literature review. Rheumatol Adv Pract 2020;4(1):rkaa004. doi: 10.1093/rap/rkaa004 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Disclosure Statement.

ACR2-8-e90161-s001.docx (34.5KB, docx)

Articles from ACR Open Rheumatology are provided here courtesy of Wiley

RESOURCES